Zander I - Search Results

1

Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.

Hartmann JT, Kopp HG, Gruenwald V, Piperno-Neumann S, Kunitz A, Hofheinz R, Mueller L, Geissler M, Horger M, Fix P, Chemnitz JM, Neise M, Wehler T, Zander I, Eckert R, Hann von Weyhern C, Bauer S, Mayer F; German Sarcoma Group within the Working Group Medical Oncology (AIO) of the German Cancer Society/AIO-STS-002, Arbeitsgemeinschaft Internistische Onkologie der Deutschen Krebsgesellschaft e.V. Hartmann JT, et al. Among authors: zander i. Eur J Cancer. 2020 Jan;124:152-160. doi: 10.1016/j.ejca.2019.10.016. Epub 2019 Nov 28. Eur J Cancer. 2020. PMID: 31785463 Clinical Trial.

2

Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.

Schuler M, Fischer JR, Grohé C, Gütz S, Thomas M, Kimmich M, Schneider CP, Laack E, Märten A; Afatinib Compassionate Use Consortium. Schuler M, et al. Oncologist. 2014 Oct;19(10):1100-9. doi: 10.1634/theoncologist.2014-0103. Epub 2014 Sep 17. Oncologist. 2014. PMID: 25232040 Free PMC article.

3

Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.

Hoffknecht P, Tufman A, Wehler T, Pelzer T, Wiewrodt R, Schütz M, Serke M, Stöhlmacher-Williams J, Märten A, Maria Huber R, Dickgreber NJ; Afatinib Compassionate Use Consortium (ACUC). Hoffknecht P, et al. J Thorac Oncol. 2015 Jan;10(1):156-63. doi: 10.1097/JTO.0000000000000380. J Thorac Oncol. 2015. PMID: 25247337 Free PMC article.

4

Pulmonary metastasectomy - A retrospective comparison of surgical outcomes after laser-assisted and conventional resection.

Franzke K, Natanov R, Zinne N, Rajab TK, Biancosino C, Zander I, Lodziewski S, Ricklefs M, Kropivnitskaya I, Schmitto JD, Haverich A, Krüger M. Franzke K, et al. Among authors: zander i. Eur J Surg Oncol. 2017 Jul;43(7):1357-1364. doi: 10.1016/j.ejso.2016.09.001. Epub 2016 Sep 29. Eur J Surg Oncol. 2017. PMID: 27771210

5

PrrT/A, a Pseudomonas aeruginosa Bacterial Encoded Toxin-Antitoxin System Involved in Prophage Regulation and Biofilm Formation.

Shmidov E, Lebenthal-Loinger I, Roth S, Karako-Lampert S, Zander I, Shoshani S, Danielli A, Banin E. Shmidov E, et al. Among authors: zander i. Microbiol Spectr. 2022 Jun 29;10(3):e0118222. doi: 10.1128/spectrum.01182-22. Epub 2022 May 16. Microbiol Spectr. 2022. PMID: 35575497 Free PMC article.

6

An Efficient, Counter-Selection-Based Method for Prophage Curing in Pseudomonas aeruginosa Strains.

Shmidov E, Zander I, Lebenthal-Loinger I, Karako-Lampert S, Shoshani S, Banin E. Shmidov E, et al. Among authors: zander i. Viruses. 2021 Feb 21;13(2):336. doi: 10.3390/v13020336. Viruses. 2021. PMID: 33670076 Free PMC article.

7

Characterization of PfiT/PfiA toxin-antitoxin system of Pseudomonas aeruginosa that affects cell elongation and prophage induction.

Zander I, Shmidov E, Roth S, Ben-David Y, Shoval I, Shoshani S, Danielli A, Banin E. Zander I, et al. Environ Microbiol. 2020 Dec;22(12):5048-5057. doi: 10.1111/1462-2920.15102. Epub 2020 Jun 24. Environ Microbiol. 2020. PMID: 32458560

8

SawR a new regulator controlling pyomelanin synthesis in Pseudomonas aeruginosa.

Ben-David Y, Zlotnik E, Zander I, Yerushalmi G, Shoshani S, Banin E. Ben-David Y, et al. Among authors: zander i. Microbiol Res. 2018 Jan;206:91-98. doi: 10.1016/j.micres.2017.10.004. Epub 2017 Oct 13. Microbiol Res. 2018. PMID: 29146265 Free article.

9

Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.

Thomay K, Fedder C, Hofmann W, Kreipe H, Stadler M, Titgemeyer J, Zander I, Schlegelberger B, Göhring G. Thomay K, et al. Among authors: zander i. Ann Hematol. 2017 Sep;96(9):1493-1500. doi: 10.1007/s00277-017-3055-1. Epub 2017 Jul 9. Ann Hematol. 2017. PMID: 28691153

10

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

Heigener DF, Schumann C, Sebastian M, Sadjadian P, Stehle I, Märten A, Lüers A, Griesinger F, Scheffler M; Afatinib Compassionate Use Consortium (ACUC). Heigener DF, et al. Oncologist. 2015 Oct;20(10):1167-74. doi: 10.1634/theoncologist.2015-0073. Epub 2015 Sep 9. Oncologist. 2015. PMID: 26354527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page